[1] LIN Q, QU M, ZHOU B, et al. Exosome-like nanoplatform modified with targeting ligand improves anti-cancer and anti-inflammation effects of imperialine [J]. Journal of controlled release : official journal of the Controlled Release Society, 2019: 104-16.
[2] GONG C, TIAN J, WANG Z, et al. Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy [J]. Journal of nanobiotechnology, 2019, 17(1): 93.
[3] KIM D, KOTHANDAN V, KIM H, et al. Noninvasive Assessment of Exosome Pharmacokinetics In Vivo: A Review [J]. Pharmaceutics, 2019, 11(12).
[4] CHEN R, XU X, QIAN Z, et al. The biological functions and clinical applications of exosomes in lung cancer [J]. Cellular and molecular life sciences : CMLS, 2019, 76(23): 4613-33.
[5] QI H, LIU C, LONG L, et al. Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy [J]. ACS nano, 2016, 10(3): 3323-33.
[6] HADLA M, PALAZZOLO S, CORONA G, et al. Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models [J]. Nanomedicine (London, England), 2016, 11(18): 2431-41.
[7] MITTAL S, GUPTA P, CHALUVALLY-RAGHAVAN P, et al. Emerging Role of Extracellular Vesicles in Immune Regulation and Cancer Progression [J]. Cancers, 2020, 12(12).
[8] LIANG Y, DUAN L, LU J, et al. Engineering exosomes for targeted drug delivery [J]. Theranostics, 2021, 11(7): 3183-95.
[9] YOU J, KANG S, RHEE W. Isolation of cabbage exosome-like nanovesicles and investigation of their biological activities in human cells [J]. Bioactive materials, 2021, 6(12): 4321-32.
[10] TENG Y, XU F, ZHANG X, et al. Plant-derived exosomal microRNAs inhibit lung inflammation induced by exosomes SARS-CoV-2 Nsp12 [J]. Molecular therapy : the journal of the American Society of Gene Therapy, 2021.
[11] KIM M, AHN J, JEON H, et al. Development of a Dunaliella tertiolecta Strain with Increased Zeaxanthin Content Using Random Mutagenesis [J]. Marine drugs, 2017, 15(6).
[12] LUO S, ALIMUJIANG A, BALAMURUGAN S, et al. Physiological and molecular responses in halotolerant Dunaliella salina exposed to molybdenum disulfide nanoparticles [J]. Journal of hazardous materials, 2021, 404: 124014.
[13] LUDWIG B, TOMASSI S, DI MARO S, et al. The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins [J]. Biomaterials, 2021, 271: 120754.
[14] JI X, HAN T, KANG N, et al. Preparation of RGD4C fused anti-TNFα nanobody and inhibitory activity on triple-negative breast cancer in vivo [J]. Life sciences, 2020, 260: 118274.
[15] BARI E, SERRA M, PAOLILLO M, et al. Silk Fibroin Nanoparticle Functionalization with Arg-Gly-Asp Cyclopentapeptide Promotes Active Targeting for Tumor Site-Specific Delivery [J]. Cancers, 2021, 13(5).
[16] SHI N, LI Y, ZHANG Y, et al. Intelligent "Peptide-Gathering Mechanical Arm" Tames Wild "Trojan-Horse" Peptides for the Controlled Delivery of Cancer Nanotherapeutics [J]. ACS applied materials & interfaces, 2017, 9(48): 41767-81.
[17] ZHANG D, HUANG Q. Encapsulation of Astragaloside with Matrix Metalloproteinase-2-Responsive Hyaluronic Acid End-Conjugated Polyamidoamine Dendrimers Improves Wound Healing in Diabetes [J]. Journal of biomedical nanotechnology, 2020, 16(8): 1229-40.
[18] MAO X, JIN F. The Exosome And Breast Cancer Cell Plasticity [J]. OncoTargets and therapy, 2019, 12: 9817-25.
[19] DESMOND B, DENNETT E, DANIELSON K. Circulating Extracellular Vesicle MicroRNA as Diagnostic Biomarkers in Early Colorectal Cancer-A Review [J]. Cancers, 2019, 12(1).
[20] RAPOSO G, STOORVOGEL W. Extracellular vesicles: exosomes, microvesicles, and friends [J]. The Journal of cell biology, 2013, 200(4): 373-83.
[21] XIE F, XU M, LU J, et al. The role of exosomal PD-L1 in tumor progression and immunotherapy [J]. Molecular cancer, 2019, 18(1): 146.
[22] DI GIOIA S, HOSSAIN M, CONESE M. Biological properties and therapeutic effects of plant-derived nanovesicles [J]. Open medicine (Warsaw, Poland), 2020, 15(1): 1096-122.
[23] MAN F, WANG J, LU R. Techniques and Applications of Animal- and Plant-Derived Exosome-Based Drug Delivery System [J]. Journal of biomedical nanotechnology, 2020, 16(11): 1543-69.
[24] MUNIR J, LEE M, RYU S. Exosomes in Food: Health Benefits and Clinical Relevance in Diseases [J]. Advances in nutrition (Bethesda, Md), 2020, 11(3): 687-96.
[25] GONABADI E, SAMADLOUIE H, SHAFAFI ZENOOZIAN M. Dunaliella salinaOptimization of culture conditions for enhanced productions in mixotrophic culture [J]. Preparative biochemistry & biotechnology, 2021: 1-9.
[26] SUI Y, HARVEY P. Dunaliella salinaEffect of Light Intensity and Wavelength on Biomass Growth and Protein and Amino Acid Composition of [J]. Foods (Basel, Switzerland), 2021, 10(5).
[27] ZHU Q, BAO J, LIU J, et al. High salinity acclimatization alleviated cadmium toxicity in Dunaliella salina: Transcriptomic and physiological evidence [J]. Aquatic toxicology (Amsterdam, Netherlands), 2020, 223: 105492.
[28] WALKER S, BUSATTO S, PHAM A, et al. Extracellular vesicle-based drug delivery systems for cancer treatment [J]. Theranostics, 2019, 9(26): 8001-17.
[29] SMYTH T, PETROVA K, PAYTON N, et al. Surface functionalization of exosomes using click chemistry [J]. Bioconjugate chemistry, 2014, 25(10): 1777-84.
[30] YANG J, WU S, HOU L, et al. Therapeutic Effects of Simultaneous Delivery of Nerve Growth Factor mRNA and Protein via Exosomes on Cerebral Ischemia [J]. Molecular therapy Nucleic acids, 2020, 21: 512-22.
[31] KIM G, KIM M, LEE Y, et al. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes [J]. Journal of controlled release : official journal of the Controlled Release Society, 2020, 317: 273-81.
[32] FAN Z, CHANG Y, CUI C, et al. Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy [J]. Nature communications, 2018, 9(1): 2605.
[33] LO W, LO S, CHEN S, et al. Molecular Imaging and Preclinical Studies of Radiolabeled Long-Term RGD Peptides in U-87 MG Tumor-Bearing Mice [J]. International journal of molecular sciences, 2021, 22(11).
[34] SHARMA M, TURAGA R, YUAN Y, et al. Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC [J]. The Journal of experimental medicine, 2021, 218(4).
[35] TIAN T, ZHANG H, HE C, et al. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy [J]. Biomaterials, 2018, 150: 137-49.
[36] LIANG G, KAN S, ZHU Y, et al. Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells [J]. International journal of nanomedicine, 2018, 13: 585-99.
[37] GU G, XIA H, HU Q, et al. PEG-co-PCL nanoparticles modified with MMP-2/9 activatable low molecular weight protamine for enhanced targeted glioblastoma therapy [J]. Biomaterials, 2013, 34(1): 196-208.
[38] HU C, LV L, PENG J, et al. MicroRNA-375 suppresses esophageal cancer cell growth and invasion by repressing metadherin expression [J]. Oncology letters, 2017, 13(6): 4769-75.
[39] ISOZAKI Y, HOSHINO I, AKUTSU Y, et al. Usefulness of microRNA‑375 as a prognostic and therapeutic tool in esophageal squamous cell carcinoma [J]. International journal of oncology, 2015, 46(3): 1059-66.
[40] HE Z, LI W, ZHENG T, et al. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression [J]. Journal of experimental & clinical cancer research : CR, 2020, 39(1): 140.
[41] ZHAO J, ZHAO Q, HU H, et al. The ASH1-miR-375-YWHAZ Signaling Axis Regulates Tumor Properties in Hepatocellular Carcinoma [J]. Molecular therapy Nucleic acids, 2018, 11: 538-53.
[42] YAO C, WANG P, LI X, et al. Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance [J]. Advanced materials (Deerfield Beach, Fla), 2016, 28(42): 9341-8.
[43] HAO Y, LI W, ZHOU X, et al. Microneedles-Based Transdermal Drug Delivery Systems: A Review [J]. Journal of biomedical nanotechnology, 2017, 13(12): 1581-97.
[44] FU Y, XIONG S. Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection [J]. Journal of controlled release : official journal of the Controlled Release Society, 2021, 335: 584-95.
[45] RAO Q, ZUO B, LU Z, et al. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro [J]. Hepatology (Baltimore, Md), 2016, 64(2): 456-72.
[46] EVANS E, JONASON A, BUSSLER H, et al. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies [J]. Cancer immunology research, 2015, 3(6): 689-701.
[47] XIE Y, DOUGAN M, JAILKHANI N, et al. Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice [J]. Proceedings of the National Academy of Sciences of the United States of America, 2019, 116(16): 7624-31.
[48] TUMEH P, HARVIEW C, YEARLEY J, et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance [J]. Nature, 2014, 515(7528): 568-71.
[49] SUK J, XU Q, KIM N, et al. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery [J]. Advanced drug delivery reviews, 2016, 99: 28-51.
[50] YU F, LIANG M, HUANG Y, et al. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling [J]. Journal of experimental & clinical cancer research : CR, 2021, 40(1): 179.
[51] LIANG G, ZHU Y, ALI D, et al. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer [J]. Journal of nanobiotechnology, 2020, 18(1): 10.
[52] ZHANG N, SONG Y, HUANG Z, et al. Monocyte mimics improve mesenchymal stem cell-derived extracellular vesicle homing in a mouse MI/RI model [J]. Biomaterials, 2020, 255: 120168.